Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Deep learning-enhanced data-driven gating improves FDG PET/CT clinical image quality.
Journal: EJNMMI physics
Published: August 09, 2025
Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson's disease.
Journal: NPJ digital medicine
Published: May 13, 2025
Ectopic, intra-thyroid parathyroid adenoma better visualized by deep learning enhanced choline PET/CT.
Journal: QJM : monthly journal of the Association of Physicians
Published: February 14, 2025
Deep learning-based time-of-flight (ToF) enhancement of non-ToF PET scans for different radiotracers.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 25, 2024
Left Atrial Appendage Closure Devices May Demonstrate Significant 18 F-FDG Uptake in the Absence of Infection.
Journal: Clinical nuclear medicine
Published: June 24, 2024
Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm.
Journal: Cambridge prisms. Precision medicine
Published: October 25, 2023
Sequential deep learning image enhancement models improve diagnostic confidence, lesion detectability, and image reconstruction time in PET.
Journal: EJNMMI physics
Published: October 22, 2023
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial.
Journal: EClinicalMedicine
Published: May 11, 2023
The impact of baseline 18F-FDG PET-CT on the management and outcome of patients with gastric cancer: a systematic review.
Journal: The British journal of radiology
Published: September 21, 2022
Reward insensitivity is associated with dopaminergic deficit in rapid eye movement sleep behaviour disorder.
Journal: Brain : a journal of neurology
Published: July 25, 2022
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial).
Journal: BMC cancer
Published: March 23, 2022
Last Updated: 09/26/2026